A pharmaceutical company, CinnaGen Pharmaceutical Co., has introduced a new locally produced autoinjector to help people diagnosed with Multiple Sclerosis. The autoinjector will help patients with just the right dosage of two vital drugs, Glatiramer Acetate and ReciGen, reducing injection pain and potential risks, reports Borna News Agency. An autoinjector is a medical device designed to deliver a single dose of a particular (typically life-saving) drug. Most autoinjectors are spring-loaded syringes. By design, autoinjectors are easy to use and are intended for self-administration by patients, or untrained personnel. There are over 80,000 people living with MS in Iran.
